This study uncovered a WNT–MDK axis that drives immune evasion in poorly differentiated hepatoblastoma, thereby providing a mechanistic basis for the immune-cold phenotype observed in aggressive tumors and highlighting MDK as a promising therapeutic target to overcome immune resistance. The gene discussed is MDK; the disease is hepatoblastoma.